ABRE Clinical Study of the Abre Venous Self-expanding Stent System

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

January 14, 2020

Study Completion Date

January 28, 2022

Conditions
Iliofemoral Venous Obstruction
Interventions
DEVICE

Abre venous self-expanding stent system

venous stent

Trial Locations (24)

10016

NYU Langone Medical Center, New York

10029

The Mount Sinai Health System, New York

11794

Stony Brook Medicine, Stony Brook

12208

Albany Medical Center, Albany

13915

Assistance Publique - Hôpitaux de Marseille - Hôpital Nord, Marseille

23507

Sentara Vascular Specialists, Norfolk

27607

NC Heart and Vascular Research, Raleigh

28203

Carolinas Medical Center, Charlotte

30309

Piedmont Atlanta Hospital, Atlanta

41125

Hesperia Hospital, Modena

43214

OhioHealth Research Institute, Columbus

48109

University of Michigan Health System, Ann Arbor

55902

Mayo Clinic, Rochester

75015

Hôpital Européen Georges Pompidou, Paris

75069

Cardiac Center of Texas, McKinney

92868

St. Joseph Hospital, Orange

98004

Lake Washington Vascular, PLLC, Bellevue

06820

The Vascular Experts, Darien

07666

Holy Name Medical Center, Teaneck

D-52074

Universitätsklinikum Aachen, Aachen

D-59759

Klinikum Arnsberg, Karolinen Hospital, Arnsberg

H91 YR71

Galway University Hospitals - University Hospital Galway, Galway

NW1 2PG

University College London Hospitals NHS Foundation Trust - University College London Hospitals, London

SE1 7EH

Guy's & St Thomas' NHS Foundation Trust - St Thomas' Hospital, London

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT03038438 - ABRE Clinical Study of the Abre Venous Self-expanding Stent System | Biotech Hunter | Biotech Hunter